08/24/2024
A drug that can regenerate teeth is set to enter human testing at Kyoto University Hospital. Following promising results in animal studies, where new teeth successfully grew in mice and ferrets, this world-first trial aims to assess the drug's efficacy and safety in human subjects. The drug functions by deactivating a protein called USAG-1, which naturally suppresses tooth growth.
By blocking USAG-1, the drug triggers bone growth and, consequently, tooth generation. If the trials are successful, this revolutionary therapy could become available within six years, offering a permanent solution for individuals of all ages who suffer from tooth loss. Apart from using drugs to regrow teeth, scientists are investigating the use of dental pulp stem cells, which reside within the tooth's pulp chamber, as well as other types of stem cells, to promote the formation of new dental tissues. These stem cells can be isolated, cultured, and then transplanted back into the patient's jawbone, where they may differentiate into odontoblasts, the cells responsible for dentin formation, or ameloblasts, the cells that produce enamel. Gene therapy is emerging as a promising avenue for tooth regeneration.
Researchers are exploring the potential of manipulating genes involved in tooth development to activate dormant tooth-forming cells. They have uncovered genes that play a crucial role in tooth formation. By delivering these genes to the appropriate cells within the jawbone, they induced the growth of tooth-like structures in animal models. On top stem cell research and gene therapy, advances in 3D printing technology have opened up new possibilities for tooth regeneration. Researchers are exploring the use of bioprinting, a specialized form of 3D printing that uses bioinks containing cells and growth factors, to create tooth-like structures.